logo

Author: Nick Little

Stock

BioXcel Therapeutics Inc (BTAI) Stock: A Comprehensive 52-Week Review

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. BioXcel Therapeutics Inc’s current trading price is -92.44% away from its 52-week high, while its distance from the 52-week low is -8.58%. The stock’s price

Industry

A Deep Dive into Eterna Therapeutics Inc (ERNA) Stock Performance

Eterna Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $2.62 on 07/17/24, and the lowest price during the same period was recorded at $0.26 on 12/19/24. 52-week price history of ERNA Stock A stock’s 52-week high

News

CNTA’s 2023 Market Dance: Up 120.48% – Time to Invest?

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 120.48% this year. Over the last six months, there has been a weaker performance of 92.86%.